LloydsPharmacy tests 10,000th patient as part of NHS Diabetes Prevention Programme

LloydsPharmacy has now tested over 10,000 patients since the NHS launched its Healthier You: Diabetes Prevention Programme in 2016.

The Diabetes Prevention Programme (NHS DPP) was designed to help people who are at higher risk of getting diabetes, by referring them to a behavioural change programme. Whilst type 1 diabetes cannot be prevented, the risk of type 2 diabetes can often be reduced by changing lifestyle and dietary habits.

Around 22,000 people with diabetes die each year in the UK. There are currently 3.4 million people with type 2 diabetes in England alone, which cost the NHS around £8.8bn a year.

Deep Patel, NHS excellence manager at Celesio UK, which includes LloydsPharmacy, says: “Type 2 diabetes is a really critical issue for the NHS and as obesity continues to rise, the cost of treatment is becoming a burden on our already stretched health service. It’s so important that we educate people about how their lifestyle can seriously impact their health. This prevention programme has been hugely successful in starting that conversation about changing their behaviour.”

Evidence shows that behavioural interventions that help people to better manage their weight and get more active can significantly reduce the risk of type 2 diabetes. The NHS Diabetes Prevention Programme is targeted at high risk patients to help them make lifestyle changes.

The service is run through GP referral and offers a free diabetes screening service through participating pharmacies. To date, as part of the programme, LloydsPharmacy has delivered over 10,000 diabetes tests since 2016.

LloydsPharmacy delivers the service in partnership with Ingeus. Peter Tickle at Ingeus comments: “Around 700 people are diagnosed with Type 2 diabetes every day in the UK, but the reality is that so many people can avoid this life-changing disease by making small, simple adjustments to their eating and exercise patterns. Patients quickly discover that it’s not difficult to achieve significant reductions in their risk, which are measurable as a result of the services provided by LloydsPharmacy.”

Deep continues: “We have pharmacy teams across the country that interact with their communities every single day. They have good relationships with patients and are ideally placed to offer advice and guidance around diabetes prevention. This programme is all about empowering people to take better care of themselves and reduce their risk of developing a condition that is often preventable.”

Helen Morgan, NHS Excellence Advisor, who looks after the programme says: “I am extremely proud to be a part of the NHS Diabetes Prevention Programme, which has been an incredible success with real long term benefits to patients. Passing the 10,000 test mark is a huge accomplishment and the real life stories we have heard on our journey are truly inspirational.”

ENDS

Notes to editors

About LloydsPharmacy:

LloydsPharmacy has around 1,600 pharmacies across the UK. These are based predominantly in community and health centre locations and include 277 LloydsPharmacy in Sainsbury’s branches. The company employs over 19,000 staff and dispenses more than 150 million prescription items annually.

LloydsPharmacy is part of the Celesio UK family which is owned by McKesson Corporation as part of McKesson Europe.

Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services.

McKesson Europe operates in 13 European countries with 39,000 employees. Every day, the company serves over 2 million customers – at more than 2,100 pharmacies of its own, at about 300 managed pharmacies and at over 5,700 participants in the brand partnership schemes. With 110 own and seven managed wholesale branches in Europe, McKesson Europe supplies more than 55,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.

McKesson Corporation, San Francisco, USA, is the majority shareholder in McKesson Europe. McKesson is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.